Guidance

Cervical screening: pathway for acceptance of new HPV tests

This guidance outlines the process for accepting new human papillomavirus (HPV) tests for use in UK cervical screening programmes.

• From: NHS England
• Published: 5 July 2019
• Last updated: 26 September 2024
  Show all updates

  1. 26 September 2024

     Added clarification that publication was originally published by Public Health England.

  2. 20 February 2024

     Added the 7. Verification of a new pre-analytic system in the 'Cervical screening: pathway for acceptance of new human papillomavirus tests' document

  3. 2 November 2020

     Added acceptance criteria and elaborated on stress test and validation report in section 3 in pathways and minor corrections in appendix A and B.

  4. 5 July 2019

     First published.

Documents

Cervical screening: pathway for acceptance of new human papillomavirus tests

Ref: PHE publications gateway number: GW-501

HTML

Appendix A: application process for commercial providers

Ref: PHE publications gateway number: GW-501

HTML

Appendix B: new technology supplier checklist

Ref: PHE publications gateway number: GW-501

HTML

Details

This document sets out:

• the pathway for accepting new human papillomavirus tests for cervical screening
• the application process for commercial providers (Appendix A)
• a checklist for commercial providers submitting information to support their application (Appendix B)

This publication was originally published by Public Health England, which closed on 30 September 2021.